"Alzevita advances early Alzheimer's detection and care with automated hippocampus segmentation for precise monitoring and personalized treatment.
Alzevita provides precise and consistent hippocampal volume measurements, reducing the chances of human error. These dependable metrics help detect subtle structural changes in the brain. Such precision enhances both clinical decision-making and research accuracy.
Hippocampal shrinkage is often one of the earliest signs of Alzheimer’s, appearing before symptoms emerge. Alzevita identifies these changes early, enabling prompt diagnosis. Early detection allows for timely treatments that may slow disease progression.
Alzevita measures hippocampal changes over time, delivering crucial insights into disease advancement. This data helps assess the effectiveness of treatments and informs personalised care strategies. Reliable monitoring supports better long-term disease management.
